AURORA, Colo.--(BUSINESS WIRE)--CytoDyn, Inc. (Pink Sheets: CYDY), is pleased to announce the commencement of a contract with Aurora, Colorado-based Litchfield Enterprises, Inc. (LEI), a 12-year-old investor relations/corporate development firm. CytoDyn is best known for Cytolin®, its developmental phase immune therapy targeted at treating early stage HIV infection. LEI will publish information related to Cytolin’s studies being conducted at a major public teaching hospital in Boston, Massachusetts, and related corporate news as it becomes available for public distribution, among other activities.
